---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-002772"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T03:08:10.326864+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# VolitionRx Q1 revenue $170k (+15% YoY); cash $11.8M; targets $10M annual cost cuts for 2025 cash flow neutrality

## Summary
- Q1 2024 revenue ~$170,000, up 15% YoY; cash and equivalents $11.8M as of March 31, 2024.
- Targeting $10M in annualized cost reductions; aiming for cash flow neutrality in 2025 via non-dilutive funding, revenue growth, and milestone payments.
- Applied for $25M in U.S. and $18M in European non-dilutive grants.
- Expects substantial Nu.Q NETs and Capture-PCR clinical data by end of June; then laser focus on commercialization.
- Volition Vet revenue expected to accelerate in H2 2024 after recent Antech and Fujifilm product launches.

## SEC filing metadata
- accession: 0001477932-24-002772
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793224002772/0001477932-24-002772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793224002772/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-002772
- JSON: https://secwatch.observer/filing/0001477932-24-002772.json
- Plain text: https://secwatch.observer/filing/0001477932-24-002772.txt

## Key facts
- Earnings Releases
  VOLITIONRX LTD reported the first quarter of 2024 results: revenue approximately $170,000 in revenue.
  - Period: the first quarter of 2024
  - Revenue: approximately $170,000 in revenue
  - Result: reported results
  source text: recorded approximately $170,000 in revenue in the first quarter of 2024, up 15% over the prior year
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793224002772/0001477932-24-002772-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.